Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster

Detalles Bibliográficos
Autores principales: Wagenhäuser, Isabell, Reusch, Julia, Gabel, Alexander, Krone, Lukas B., Kurzai, Oliver, Petri, Nils, Krone, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841732/
https://www.ncbi.nlm.nih.gov/pubmed/36657489
http://dx.doi.org/10.1016/j.cmi.2023.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841732/
https://www.ncbi.nlm.nih.gov/pubmed/36657489
http://dx.doi.org/10.1016/j.cmi.2023.01.008

Ejemplares similares